Browse > Article
http://dx.doi.org/10.14348/molcells.2018.0109

EZH2-Mediated microRNA-139-5p Regulates Epithelial-Mesenchymal Transition and Lymph Node Metastasis of Pancreatic Cancer  

Ma, Jin (Department of Gastroenterology, Luwan Branch of Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine)
Zhang, Jun (Department of General Surgery, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine)
Weng, Yuan-Chi (Department of General Surgery, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine)
Wang, Jian-Cheng (Department of General Surgery, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine)
Publication Information
Molecules and Cells / v.41, no.9, 2018 , pp. 868-880 More about this Journal
Abstract
Pancreatic cancer (PC) is one of the most aggressive cancers presenting with high rates of invasion and metastasis, and unfavorable prognoses. The current study aims to investigate whether EZH2/miR-139-5p axis affects epithelial-mesenchymal transition (EMT) and lymph node metastasis (LNM) in PC, and the mechanism how EZH2 regulates miR-139-5p. Human PC and adjacent normal tissues were collected to determine expression of EZH2 and miR-139-5p, and their relationship with clinicopathological features of PC. Human PC cell line was selected, and treated with miR-139-5p mimics/inhibitors, EZH2 vector or shEZH2 in order to validate the regulation of EZH2-mediated miR-139-5p in PC cells. Dual-luciferase report gene assay and chromatin immunoprecipitation assay were employed to identify the relationship between miR-139-5p and EZH2. RT-qPCR and Western blot analysis were conducted to determine the expression of miR-139-5p, EZH2 and EMT-related markers and ZEB1/2. Tumor formation ability and in vitro cell activity were also analyzed. Highly-expressed EZH2 and poorly-expressed miR-139-5p were detected in PC tissues, and miR-139-5p and EZH2 expressions were associated with patients at Stage III/IV, with LNM and highly-differentiated tumors. EZH2 suppressed the expression of miR-139-5p through up-regulating Histone 3 Lysine 27 Trimethylation (H3K27me3). EMT, cell proliferation, migration and invasion were impeded, and tumor formation and LNM were reduced in PC cells transfected with miR-139-5p mimics and shEZH2. MiR-139-5p transcription is inhibited by EZH2 through up-regulating H3K27me3, thereby down-regulation of EZH2 and up-regulation of miR-139-5p impede EMT and LNM in PC. In addition, the EZH2/miR-139-5p axis presents as a promising therapeutic strategy for the treatment of PC.
Keywords
enhancer of zeste homolog 2; epithelial-mesenchymal transition; lymph node metastasis; microRNA-139-5p; pancreatic cancer; proliferation;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Gayral, M., Jo, S., Hanoun, N., Vignolle-Vidoni, A., Lulka, H., Delpu, Y., Meulle, A., Dufresne, M., Humeau, M., Chalret du Rieu, M., et al. (2014). MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer. World J. Gastroenterol. 20, 11199-11209.   DOI
2 Han, T., Jiao, F., Hu, H., Yuan, C., Wang, L., Jin, Z.L., Song, W.F., and Wang, L.W. (2016). EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer. Oncotarge. 7, 11194-11207.
3 Hartwig, W., and Buchler, M.W. (2013). Pancreatic cancer: current options for diagnosis, staging and therapeutic management. Gastrointest Tumors 1, 41-52.   DOI
4 Hu, W., Jia, X., Gao, Y., and Zhang, Q. (2018). Chaetospirolactone reverses the apoptotic resistance towards TRAIL in pancreatic cancer. Biochem. Biophys. Res. Commun. 495, 621-628.   DOI
5 Hu, Y., Deng, C., Zhang, H., Zhang, J., Peng, B., and Hu, C. (2017). Long non-coding RNA XIST promotes cell growth and metastasis through regulating miR-139-5p mediated Wnt/beta-catenin signaling pathway in bladder cancer. Oncotarget 8, 94554-94568.
6 Jin, X., Yang, C., Fan, P., Xiao, J., Zhang, W., Zhan, S., Liu, T., Wang, D., and Wu, H. (2017). CDK5/FBW7-dependent ubiquitination and degradation of EZH2 inhibits pancreatic cancer cell migration and invasion. J. Biol. Chem. 292, 6269-6280.   DOI
7 Kim, K., Lu, Z., and Hay, E.D. (2002). Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol. Int. 26, 463-476.   DOI
8 Kim, T., Veronese, A., Pichiorri, F., Lee, T.J., Jeon, Y.J., Volinia, S., Pineau, P., Marchio, A., Palatini, J., Suh, S.S., et al. (2011). p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J. Exp. Med. 208, 875-883.   DOI
9 Li, J., Su, L., Gong, Y.Y., Ding, M.L., Hong, S.B., Yu, S., and Xiao, H.P. (2017). Downregulation of miR-139-5p contributes to the antiapoptotic effect of liraglutide on the diabetic rat pancreas and INS-1 cells by targeting IRS1. PLoS One 12, e0173576.   DOI
10 Li, Q., Liang, X., Wang, Y., Meng, X., Xu, Y., Cai, S., Wang, Z., Liu, J., and Cai, G. (2016). miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2. Sci. Rep. 6, 27157.   DOI
11 Liu, C., Cheng, H., Shi, S., Cui, X., Yang, J., Chen, L., Cen, P., Cai, X., Lu, Y., Wu, C., et al. (2013). MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3. Curr. Mol. Med. 13, 467-478.   DOI
12 Livak, K.J., and Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408.   DOI
13 Ma, Z., Huang, H., Wang, J., Zhou, Y., Pu, F., Zhao, Q., Peng, P., Hui, B., Ji, H., and Wang, K. (2017). Long non-coding RNA SNHG15 inhibits P15 and KLF2 expression to promote pancreatic cancer proliferation through EZH2-mediated H3K27me3. Oncotarget 8, 84153-84167.
14 Yonemori, M., Seki, N., Yoshino, H., Matsushita, R., Miyamoto, K., Nakagawa, M., and Enokida, H. (2016). Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer. Cancer Sci. 107, 1233-1242.   DOI
15 Miao, F., Zhu, J., Chen, Y., Tang, N., Wang, X., and Li, X. (2016). MicroRNA-183-5p promotes the proliferation, invasion and metastasis of human pancreatic adenocarcinoma cells. Oncol. Lett. 11, 134-140.   DOI
16 Sun, D., Layer, R., Mueller, A.C., Cichewicz, M.A., Negishi, M., Paschal, B.M., and Dutta, A. (2014). Regulation of several androgeninduced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells. Oncogene 33, 1448-1457.   DOI
17 Sun, C., Sang, M., Li, S., Sun, X., Yang, C., Xi, Y., Wang, L., Zhang, F., Bi, Y., Fu, Y., et al. (2015). Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met. Oncotarget 6, 39756-39792.
18 Xu, J., Zhu, W., Xu, W., Yao, W., Zhang, B., Xu, Y., Ji, S., Liu, C., Long, J., Ni, Q., et al. (2013). Up-regulation of MBD1 promotes pancreatic cancer cell epithelial-mesenchymal transition and invasion by epigenetic down-regulation of E-cadherin. Curr. Mol. Med. 13, 387-400.
19 Yang, Q., Wang, Y., Lu, X., Zhao, Z., Zhu, L., Chen, S., Wu, Q., Chen, C., and Wang, Z. (2015). MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells. Oncotarget 6, 3268-3279.
20 Zhang, H.D., Jiang, L.H., Sun, D.W., Li, J., and Tang, J.H. (2015). MiR-139-5p: promising biomarker for cancer. Tumour Biol. 36, 1355-1365.   DOI
21 Zhang, Z., Che, X., Yang, N., Bai, Z., Wu, Y., Zhao, L., and Pei, H. (2017). miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2. Biomed. Pharmacother. 96, 1341-1348.   DOI
22 Sclafani, F., Iyer, R., Cunningham, D., and Starling, N. (2015). Management of metastatic pancreatic cancer: Current treatment options and potential new therapeutic targets. Crit. Rev. Oncol. Hematol. 95, 318-336.   DOI
23 Zhang, J., Zhang, L., Li, C., Yang, C., Li, L., Song, S., Wu, H., Liu, F., Wang, L., and Gu, J. (2018). LOX-1 is a poor prognostic indicator and induces epithelial-mesenchymal transition and metastasis in pancreatic cancer patients. Cell Oncol (Dordr). 41, 73-84.
24 Mody, H.R., Hung, S.W., AlSaggar, M., Griffin, J., and Govindarajan, R. (2016). Inhibition of S-adenosylmethionine-dependent methyltransferase attenuates TGF${\beta}$1-Induced EMT and metastasis in pancreatic cancer: putative roles of miR-663a and miR-4787-5p. Mol. Cancer Res. 14, 1124-1135.   DOI
25 Ougolkov, A.V., Bilim, V.N., and Billadeau, D.D. (2008). Regulation of pancreatic tumor cell proliferation and chemoresistance by the histone methyltransferase enhancer of zeste homologue 2. Clin. Cancer Res. 14, 6790-6796.   DOI
26 Qi, W., Zhao, K., Gu, J., Huang, Y., Wang, Y., Zhang, H., Zhang, M., Zhang, J., Yu, Z., Li, L., et al. (2017). An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED. Nat. Chem. Biol. 13, 381-388.   DOI
27 Reijm, E.A., Timmermans, A.M., Look, M.P., Meijer-van Gelder, M.E., Stobbe, C.K., van Deurzen, C.H., Martens, J.W., Sleijfer, S., Foekens, J.A., Berns, P.M., et al. (2014). High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer. Ann. Oncol. 25, 2185-2190.   DOI
28 Shen, K., Mao, R., Ma, L., Li, Y., Qiu, Y., Cui, D., Le, V., Yin, P., Ni, L., and Liu, J. (2014). Post-transcriptional regulation of the tumor suppressor miR-139-5p and a network of miR-139-5p-mediated mRNA interactions in colorectal cancer. FEBS J. 281, 3609-3624.   DOI
29 Wang, Y., Li, J., Xu, C., and Zhang, X. (2017). MicroRNA-139-5p inhibit cell proliferation and invasion by targeting RHO-associated coiled-coil containing protein kinase 2 in ovarian cancer. Oncol. Res. doi: 10.3727/096504017X14974343584989. [Epub ahead of print].   DOI
30 Siegel, R.L., Miller, K.D., and Jemal, A. (2017). Cancer Statistics, 2017. CA Cancer J. Clin. 67, 7-30.   DOI
31 Chen, Y., Xie, D., Yin Li, W., Man Cheung, C., Yao, H., Chan, C.Y., Chan, C.Y., Xu, F.P., Liu, Y.H., Sung, J.J., et al. (2010). RNAi targeting EZH2 inhibits tumor growth and liver metastasis of pancreatic cancer in vivo. Cancer Lett. 297, 109-116.   DOI
32 Adsay, N.V., Bagci, P., Tajiri, T., Oliva, I., Ohike, N., Balci, S., Gonzalez, R.S., Basturk, O., Jang, K.T., and Roa, J.C. (2012). Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement. Semin Diagn Pathol. 29, 127-141.   DOI
33 Au, S.L., Wong, C.C., Lee, J.M., Fan, D.N., Tsang, F.H., Ng, I.O., and Wong, C.M. (2012). Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis. Hepatology 56, 622-631.   DOI
34 Bian, Z., Zhang, J., Li, M., Feng, Y., Yao, S., Song, M., Qi, X., Fei, B., Yin, Y., Hua, D., et al. (2017). Long non-coding RNA LINC00152 promotes cell proliferation, metastasis, and confers 5-FU resistance in colorectal cancer by inhibiting miR-139-5p. Oncogenesis 6, 395.   DOI
35 Cao, Q., Yu, J., Dhanasekaran, S.M., Kim, J.H., Mani, R.S., Tomlins, S.A., Mehra, R., Laxman, B., Cao, X., Yu, J., et al. (2008). Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 27, 7274-7284.   DOI
36 Chen, L., Ma, C., Bian, Y., Shao, C., Wang, T., Li, J., Chong, X., Su, L., and Lu, J. (2017). Aberrant expression of STYK1 and E-cadherin confer a poor prognosis for pancreatic cancer patients. Oncotarget 8, 111333-111345.
37 Di Leva, G., and Croce, C.M. (2010). Roles of small RNAs in tumor formation. Trends Mol Med. 16, 257-267.   DOI
38 Feng, H., Wang, Y., Su, J., Liang, H., Zhang, C.Y., Chen, X., and Yao, W. (2016). MicroRNA-148a suppresses the proliferation and migration of pancreatic cancer cells by down-regulating ErbB3. Pancreas 45, 1263-1271.   DOI
39 Ebrahimi, S., Hosseini, M., Ghasemi, F., Shahidsales, S., Maftouh, M., Akbarzade, H., Parizadeh, S.A., Hassanian, S.M., and Avan, A. (2016). Circulating microRNAs as potential diagnostic, prognostic and therapeutic targets in pancreatic cancer. Curr. Pharm. Des. 22, 6444-6450.